BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15197981)

  • 1. [Liver failure].
    Yoshiba M
    Nihon Rinsho; 2004 May; 62 Suppl 5():545-9. PubMed ID: 15197981
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood purification for patients with chronic renal failure accompanied by severe liver disease].
    Inoue K; Yoshiba M
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():66-9. PubMed ID: 15250270
    [No Abstract]   [Full Text] [Related]  

  • 3. [Apheresis treatment for fulminant hepatitis].
    Tateishi Y; Hirasawa H; Nitta M
    Nihon Rinsho; 2004 May; 62 Suppl 5():462-6. PubMed ID: 15197964
    [No Abstract]   [Full Text] [Related]  

  • 4. [The recent progress in blood purification in critical care: overview].
    Moriguchi T; Hirasawa H; Oda S; Shiga H; Matsuda K; Hirayama Y
    Nihon Rinsho; 2004 May; 62 Suppl 5():397-402. PubMed ID: 15197952
    [No Abstract]   [Full Text] [Related]  

  • 5. [Coping with shortage of plasma and albumin: a strategy for artificial liver].
    HUANG JR; YUAN WX
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):330-1. PubMed ID: 19497194
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of the prognosis of severe hepatitis treated with molecular adsorbent recycling system (MARS) using MELD score].
    Sun LH; Zhang YX; Xiao L; Lu XB
    Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):632, 635. PubMed ID: 16093004
    [No Abstract]   [Full Text] [Related]  

  • 7. Artificial liver support system in China: a review over the last 30 years.
    Li LJ; Zhang YM; Liu XL; Du WB; Huang JR; Yang Q; Xu XW; Chen YM
    Ther Apher Dial; 2006 Apr; 10(2):160-7. PubMed ID: 16684218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The evaluation for principles and clinical application of combined artificial liver therapy].
    GUO LM
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):326-7. PubMed ID: 19497192
    [No Abstract]   [Full Text] [Related]  

  • 9. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.
    Di Campli C; Santoro MC; Gaspari R; Merra G; Zileri Dal Verme L; Zocco MA; Piscaglia AC; Di Gioacchino G; Novi M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
    Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined twice-daily plasma exchange and continuous veno-venous hemodiafiltration for bridging severe acute liver failure.
    Biancofiore G; Bindi LM; Urbani L; Catalano G; Mazzoni A; Scatena F; Mosca F; Filipponi F
    Transplant Proc; 2003 Dec; 35(8):3011-4. PubMed ID: 14697964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of artificial liver support system on chronic sever hepatitis patients].
    Shang J; Jia BL; Zhang HP; Chen P; Jin X
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):506. PubMed ID: 12939194
    [No Abstract]   [Full Text] [Related]  

  • 12. Artificial liver support system for fulminant hepatic failure as bridge-use to living donor liver transplantation.
    Ichida T
    Intern Med; 2003 Oct; 42(10):920-1. PubMed ID: 14606698
    [No Abstract]   [Full Text] [Related]  

  • 13. Artificial liver support at present and in the future.
    Onodera K; Sakata H; Yonekawa M; Kawamura A
    J Artif Organs; 2006; 9(1):17-28. PubMed ID: 16614798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial liver support systems.
    Monga A; Jain SK
    J Assoc Physicians India; 1999 Nov; 47(11):1092-9. PubMed ID: 10862321
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of severe hepatitis treated with a hybrid artificial liver support system].
    Li LJ; Yang Q; Huang JR; Li J; Cao HC; Chen YM; Chen YG; Cheng JF; Fu SZ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):458-60. PubMed ID: 12939173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is plasma exchange effective in prevention of hepatic transplantation in fulminant Wilson disease with hepatic failure?
    Akyildiz BN; Yildirim S; Kondolot M; Arslan D
    J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):778-80. PubMed ID: 21593651
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged artificial liver support in a child with fulminant hepatic failure.
    Okamoto K; Kurose M; Ikuta Y; Ogata K; Harada T; Takeda K; Sato T
    ASAIO J; 1996; 42(3):233-5. PubMed ID: 8725697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial hepatic support. Where are we now?
    Davenport A
    Blood Purif; 2001; 19(1):1-3. PubMed ID: 11190653
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma exchange-based plasma recycling dialysis system as a potential platform for artificial liver support.
    Nishimura A; Umehara Y; Umehara M; Hakamada K; Narumi S; Toyoki Y; Yoshihara S; Sasaki M
    Artif Organs; 2006 Aug; 30(8):629-33. PubMed ID: 16911318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Falsely low calcium measurements after high volume plasma exchange in a patient with liver failure.
    Miller JP; Mintz PD
    Transfus Sci; 1994 Sep; 15(3):299-302. PubMed ID: 10161259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.